biotech research

Growing garage-type hedge fund trading financial derivatives is looking for an analyst with at least nine months of experience in the biotech world, preferably a USA one.

Your work-on-contract will include analysis of stock provided and the creation of a 2-3 page (including images) analysis of a particular catalyst (ex: data release, AdComm meeting, etc.) shortly, with the event being max one qtr out.

A perfect example of such a report can be found in the attached files.
Highlighted in yellow is what I am looking for from the report you will be providing me. Other information is highly relevant but can be further summarised and more concise.

The profit you will make from this, as an analyst:
– $80 for a report itself.
– 10% of the profit from the trade we take, with up to 600$ of clean earnings for you as an analyst.

Such a work model would ensure that reports are as good as they can be, as there is the benefit of you succeeding while working with us.

Kindly note that if your first report and trade we take is reasonably successful, we would like to work long-term with you as an analyst.

P.S.
Our Strategy is effectively volatility betting. Therefore, we are direction neutral. No matter what advice the underlying stock would move – we will profit if the % move exceeds the specific percentages we pay in commissions for such a position and insurance. For further explanation of the Strategy and funds we as a fund have under management, I invite you to DM’s.